16 June 2020
Statement from the Chief Investigators: low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
Comunicado dos Pesquisadores Principais do estudo “Avaliação randomizada de terapias para a COVID-19” (RECOVERY) sobre dexametasona, 16 de junho de 2020
Comunicado de prensa de la Universidad de Oxford: Dexametasona reduce la mortalidad hasta un tercio en pacientes hospitalizados con complicaciones severas por COVID-19
The preliminary results of the dexamethasone comparison have been published on medRxiv.
Preliminary report published in The New England Journal of Medicine.
Meta-analysis including the RECOVERY trial published in JAMA.
